Clinical Trials Directory

Trials / Unknown

UnknownNCT04807231

Comparison Between Calculated Bioavailable Testosterone Level With Radio-immunoassay Result.

Status
Unknown
Phase
Study type
Observational
Enrollment
270 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Currently, the gold standard to obtain bioavailable testosterone results is radioimmunoassay (RIA). However, this assay requires specific equipment. Giton in 2006 proposed an optimized calculation of the Vermeulen equation, the results of which seem to be well correlated with those obtained by RIA. The aim of this study is to determine if the bioavailable testosterone levels determined by both methods are similar in order to replace the usual RIA assay of bioavailable testosterone by this calculation.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood withdrawalBlood withdrawal in order to perform a bioavailable testosterone RIA (Radio-Immuno Assay).

Timeline

Start date
2021-03-11
Primary completion
2024-03-01
Completion
2024-03-01
First posted
2021-03-19
Last updated
2023-04-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04807231. Inclusion in this directory is not an endorsement.

Comparison Between Calculated Bioavailable Testosterone Level With Radio-immunoassay Result. (NCT04807231) · Clinical Trials Directory